Literature DB >> 7353904

Impaired neutrophil locomotion during acute bacterial infections.

D Althaus, H U Keller, M W Hess, H Cottier.   

Abstract

Neutrophils from patients with acute bacterial infections show a marked decrease in random as well as directional locomotion in vitro. The further analysis of the data suggests that defective directional locomotion is due to impaired locomotion and not to impaired chemotaxis. The defect disappeared almost completely with clinical recovery. There was no direct correlation between impaired directional neutrophil locomotion and the proportion of band forms in the neutrophil population. Plasma obtained from patients with acute bacterial infections showed no 'spontaneous' chemotactic activity and immune complex-induced cytotaxin formation was normal in vitro. Neutrophils from 2 patients with viral pneumonia showed normal locomotion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353904     DOI: 10.1159/000232454

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

2.  Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis.

Authors:  T Ternowitz; T Herlin
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors.

Authors:  K T Hartiala; L Langlois; I M Goldstein; J T Rosenbaum
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome.

Authors:  P Ruutu; E Savilahti; H Repo; T U Kosunen
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.